Wednesday, September 23, 2020 The Canadian Cancer Trials Group (CCTG) is pleased to announce that our Director, Dr. Janet Dancey, has been elected to the Canadian Academy of Health Sciences (CAHS), which represents Canadian health sciences internationally and informs solutions that improve the health of all Canadians. Dr. Dancey is an international leader in cancer clinical trials of experimental therapeutics and has special expertise in new anti-cancer drug development, linking drug and biomarker development, and associated clinical trials methodology, including development of novel trials for patients with rare tumours. As Director, she has advanced CCTG’s research strategy and expanded its portfolio dramatically. A prolific author with an excellent citation record, she is a sought-after speaker, both nationally and internationally. We would also like to congratulate all of the 77 new 2020 CAHS Fellows with special mention to our CCTG colleagues: Gregory Cairncross Director, Charbonneau Cancer Institute and Professor, Clinical Neurosciences and Oncology, University of Calgary David Huntsman Professor, University of British Columbia Wilson H. Miller Jr. Medical Oncologist, Jewish General Hospital Stuart Peacock Professor and Leslie Diamond Chair in Cancer Survivorship, Simon Fraser University Brent Schacter Professor Emeritus, Department of Internal Medicine, University of Manitoba Barbara Vanderhyden Professor, Senior Scientist, and Corinne Boyer Chair of Ovarian Cancer Research, University of Ottawa and The Ottawa Hospital For more information
